CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bayer Pharma AG v. Alembic Pharmaceuticals Limited

1:15-cv-00832

Overview

Case Number 1:15-cv-00832
Filing Date 2015-09-18
Status Terminated
Termination Date 2017-09-26
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Alembic Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Adam Wyatt Poff

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Alembic Global Holding S/A Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Alembic Pharmaceuticals Limited NPE (University / Research)

Represented By

6 Attorneys Listed

Rami Bardenstein

UNDELIVERABLE 12/28/2016

UNDELIVERABLE 12/28/2016

Pilar Gabrielle Kraman

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 576-3586

Rodney Square, 1000 North King Street

Nirav N. Desai

Email: ndesai@sternekessler.com

Krishan Y. Thakker

Email: kthakker@skgf.com

Hemant Keeto Sabharwal

Email: keeto.sabharwal@pillsburylaw.com

Adam Wyatt Poff

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Plaintiff

Bayer HealthCare Pharmaceuticals Inc. Operating Company

Represented By

2 Attorneys Listed

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Bayer Intellectual Property GMBH Operating Company

Represented By

2 Attorneys Listed

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Bayer Pharma AG NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇩🇪 Germany 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8613950
Pharmaceutical forms with improved pharmacokinetic properties
Filed: 2006-02-16
Issued: 2013-12-24
Active (3.0 yrs remaining) +1376d PTA
Expires: 2029-11-23

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1376 days) / Cellect Scrutiny — Over 1376 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

11

Dispositive

0

Granted

0

Denied

0

Pending / Review

5

Motions by Category

Procedural / Extension Motion 10 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED - re 29 STIPULATION TO EXTEND TIME to file a proposed protective order to 14 days after the Court rules on the motion to consolidate filed by Bayer H...
Entry #— • 2016-02-01
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to file a proposed protective order to 14 days after the Court rules on the motion to consolidate - filed by Bayer HealthCare Pharmac...
Entry #29 • 2016-01-29 Document →
Claim Construction / Markman Filing Pending
ORAL ORDER re 19 Joint Status Report - The proposed schedule, which aligns with the schedule in related case 15-cv-464 GMS, is ADOPTED. The Court will further a...
Entry #— • 2016-01-07
Procedural / Extension Motion Pending
SO ORDERED - re 21 Joint STIPULATION TO EXTEND TIME to file Answering and Reply Briefs regarding Plaintiffs' Motion to Consolidate Actions (D.I. 20) to January ...
Entry #— • 2015-12-18
Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME to file Answering and Reply Briefs regarding Plaintiffs' Motion to Consolidate Actions (D.I. 20) to January 11, 2016 and Januar...
Entry #21 • 2015-12-17 Document →
Procedural / Extension Motion Pending
SO ORDERED - re 17 Joint STIPULATION TO EXTEND TIME for the parties to file the Joint Status Report to December 11, 2015 filed by Bayer HealthCare Pharmaceutica...
Entry #— • 2015-12-11

Docket Entries

(74 total)
Pleading / Complaint

COMPLAINT filed against Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1789782.) - filed by Bayer Pharma AG, Bayer Intellectual Property GMBH, Bayer HealthCare Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(sec) (Entered: 09/18/2015)

Entry #1 • 2015-09-18
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 09/18/2015)

Entry #2 • 2015-09-18
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/07/2015. Date of Expiration of Patent: 12/23/2028.Thirty Month Stay Deadline: 2/7/2018. (sec) (Entered: 09/18/2015)

Entry #3 • 2015-09-18
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,613,950 B2. (sec) (Entered: 09/18/2015)

Entry #4 • 2015-09-18
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer HealthCare Pharmaceuticals Inc., Bayer Intellectual Property GMBH, Bayer Pharma AG filed by Bayer HealthCare Pharmaceuticals Inc., Bayer Intellectual Property GMBH, Bayer Pharma AG. (sec) (Entered: 09/18/2015)

Entry #5 • 2015-09-18
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc